Related Experiment Video
Updated: Jul 14, 2026

05:21
Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay
Published on: September 13, 2024
Anti-tumor 12-deoxyphorbol esters from Euphorbia cornigera
Imam Bakhsh Baloch1, Musa Kaleem Baloch, Qazi Najam us Saqib
1Department of Chemistry, Gomal University, Dera Ismail Khan, Pakistan.
European Journal of Medicinal Chemistry
|May 22, 2007
Summary
New compounds from Euphorbia cornigera roots show potent cytotoxic activity against human KB cells. Compounds 8-10 exhibit significant cell death induction by damaging DNA, highlighting their therapeutic potential.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Molecular Biology
Background:
- Euphorbia species are a rich source of bioactive natural products.
- Diterpenoids, such as phorbol esters, are known for their diverse biological activities.
Purpose of the Study:
- To isolate and characterize new compounds from Euphorbia cornigera roots.
- To evaluate the cytotoxic and DNA-damaging activities of isolated compounds.
Main Methods:
- Isolation and structural elucidation using extensive NMR spectroscopy (1H, 13C, COSY-45, HOHAHA, HMQC, HMBC, NOE).
- Cytotoxicity assessment via MTT assay on human KB cells.
- Investigation of DNA synthesis inhibition using Trypan blue exclusion and Brd-U assays.
Main Results:
- Eleven compounds were isolated, including nine new diesters of 12-deoxyphorbol (1-10) and one acetyl derivative (11).
- Compounds 8-10 demonstrated significant cytotoxic activity with IC50 values of 0.8, 0.5, and 1.0 microg/mL, respectively.
- Compounds 8-10 inhibited DNA synthesis and induced DNA cross-linking and strand breaks, correlating with their cytotoxicity.
Conclusions:
- The isolated 12-deoxyphorbol derivatives possess potent cytotoxic properties against human KB cells.
- The mechanism of cell death involves DNA damage, including cross-linking and strand breaks.
- These findings suggest potential therapeutic applications for these compounds in cancer treatment.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

